Image-1 (37fc8b27 Bf23 4fe6 8d44 5331bde5b466 01)
Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4606
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 70518-4606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (3cb2c28c Eb1b 4e9c Bce3 Ba8e52283221 771 1)
Image (3cb2c28c Eb1b 4e9c Bce3 Ba8e52283221 802 1)
Remedy_label (Remedy Label)
This is a medication label for Sertraline HCI tablets, with a recommended usual dosage stated to be included in the insert. It is advised to keep the medication out of the reach of children, store at a temperature range of 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). The NDC number is 70518-4606-01. The medication is repackaged by RemedyRepack, a company located in Indiana, PA, USA.*
Mm1 (Sertraline HCl 25mg 70518 4606 00)
This text provides information about Sertraline HCI tablets, including dosage instructions, storage conditions, quantity per box, NDC number, and packaging details. It also indicates that the tablets are repackaged by RemedyRepack Inc. in Indiana, PA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
